NCT04597268View on ClinicalTrials.gov

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 15, 2022

Study Completion Date

December 30, 2022

Conditions
Sedation and Analgesia
Interventions
DRUG

Dexmedetomidine

intravenous dexmedetomidine 1 mic/kg

DRUG

Ketamine

ketamine 1mg/kg

DRUG

Midazolam

midazolam 0.05 mg/kg

Trial Locations (1)

11796

Walaa Y Elsabeeny, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT04597268 - Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures | Biotech Hunter | Biotech Hunter